Spiriva Respimat

Spiriva Respimat Liều dùng/Hướng dẫn sử dụng

tiotropium bromide

Nhà sản xuất:

Boehringer Ingelheim
Thông tin kê toa chi tiết tiếng Anh
Dosage/Direction for Use
The recommended dosage of SPIRIVA RESPIMAT is inhalation of the spray of two puffs once daily from the RESPIMAT inhaler at the same time of day (see Instructions for Use under Cautions for Usage).
The recommended dose should not be exceeded.
In the treatment of asthma, the full benefits will be apparent after several doses of SPIRIVA RESPIMAT.
Special populations: Elderly patients can use SPIRIVA RESPIMAT at the recommended dose.
Renally impaired patients can use SPIRIVA RESPIMAT at the recommended dose. However, as with all predominantly renally excreted drugs, SPIRIVA RESPIMAT use should be cautioned & monitored closely in patients with moderate to severe renal impairment.
Hepatically impaired patients can use SPIRIVA RESPIMAT at the recommended dose.
Paediatric population (age below 18 years): COPD does not normally occur in children. The safety and effectiveness of SPIRIVA RESPIMAT in paediatric patients have not been established.
The efficacy and safety of SPIRIVA RESPIMAT in paediatric patients with asthma has not yet been established.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in